Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life-A Narrative Review.
Viviana ElianVioleta PopoviciEmma-Adriana OzonAdina Magdalena MusucAncuța Cătălina FițaEmilia RusuGabriela RadulianDumitru LupuliasaPublished in: Life (Basel, Switzerland) (2023)
Type 1 diabetes mellitus is a chronic autoimmune disease that affects millions of people and generates high healthcare costs due to frequent complications when inappropriately managed. Our paper aimed to review the latest technologies used in T1DM management for better glycemic control and their impact on daily life for people with diabetes. Continuous glucose monitoring systems provide a better understanding of daily glycemic variations for children and adults and can be easily used. These systems diminish diabetes distress and improve diabetes control by decreasing hypoglycemia. Continuous subcutaneous insulin infusions have proven their benefits in selected patients. There is a tendency to use more complex systems, such as hybrid closed-loop systems that can modulate insulin infusion based on glycemic readings and artificial intelligence-based algorithms. It can help people manage the burdens associated with T1DM management, such as fear of hypoglycemia, exercising, and long-term complications. The future is promising and aims to develop more complex ways of automated control of glycemic levels to diminish the distress of individuals living with diabetes.
Keyphrases
- glycemic control
- type diabetes
- artificial intelligence
- blood glucose
- machine learning
- deep learning
- weight loss
- healthcare
- insulin resistance
- end stage renal disease
- big data
- physical activity
- chronic kidney disease
- risk factors
- low dose
- peritoneal dialysis
- young adults
- newly diagnosed
- high throughput
- health insurance
- patient reported
- affordable care act